Latest equipment developments that can see and report microbial bioburden in air and water as it happens, will be presented, with how it fits with Annex 1 compliance explained
23-24 April 2024
Coventry Building Society Arena
Latest equipment developments that can see and report microbial bioburden in air and water as it happens, will be presented, with how it fits with Annex 1 compliance explained
Microfluidic chips have revolutionized the manufacturing of lipid nanoparticles and the development of novel drug delivery systems. The use of microfluidic devices offers great advantages in the optimization of lipid nanoparticles with decreased experimental times, complex flows, excellent mixing and high reproducibility. Our studies have demonstrated the continuous manufacturing of lipid nanoparticles varying from conventional… Read more »
Homegrown 3D printing was thrust into the global mainstream as a temporary healthcare solution to support efforts to fight COVID-19, but with global supply chains still reeling from the pandemic, there continues to be a focus on building resilient, long-term, production capabilities across the pharmaceutical industry. This presentation takes a unique approach to detailing how… Read more »